However, AAV‐miR‐29a and DAPT were found to inhibit deposition of chondroid matrix in valves, which indicated that the Notch1 pathway may serve as a key therapeutic target in VC of CKD rats. This evidence concerns the gene NOTCH1 and chronic kidney disease.